Evaluation of antiviral effects of the combination therapy of daclatasvir and asunaprevir
Not Applicable
Recruiting
- Conditions
- chronic hepatitis C with genotype 1
- Registration Number
- JPRN-UMIN000016995
- Lead Sponsor
- Gunma University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients having the history of allergy to Daclatasvir and Asunaprevir 2. Women with pregnancy, having a possibility of pregnancy and during lactation 3. Patients taking a medicine described as a contraindication in a package insert. However, these patients can participate the study one month after discontinuation of the drug. 4. Patients whom the primary doctor thinks inapproprioate for participating the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method